Latest Headlines

  1. Department Of Immunology, Institute Of Microbiology, Bulgarian Academy Of Sciences And Enzolytics, Inc. Execute Three Year Agreement 9/9/2024

    Enzolytics, Inc. ("enzolytics.com") (the "Company") announced today that the Company and the Stephan Angeloff Institute of Microbiology, Department of Immunology, Institute of Microbiology, Bulgarian Academy of Sciences, represented by Professor Tchorbanov PhD, Head of the Department of Immunology and Penka Petrova PHD, DSc, Director of the Institute of Microbiology, entered into a three year agreement to combine their efforts to accelerate discovery of combined applications and commercialization of their individual entity technologies.

  2. Medical University Of Graz Selects The HALO AP Digital Pathology Platform To Deliver Comprehensive Diagnostics 9/6/2024

    The Diagnostics & Research Institute for Pathology at the Medical University of Graz, a leader in personalized patient care and one of the largest hospitals in Austria, has selected the HALO AP digital pathology platform from Indica Labs to deliver primary diagnostics.

  3. Integrated DNA Technologies Bolsters Comprehensive Genomic Profiling Solutions With Launch Of New Archer HRD Technology For Cancer Research 9/6/2024

    With a history of driving innovation and collaboration in next generation sequencing (NGS), Integrated DNA Technologies is expanding its Archer portfolio of comprehensive genomic profiling (CGP) solutions to include homologous recombination deficiency (HRD) assessment.

  4. Association For Diagnostics & Laboratory Medicine (Formerly AACC) Survey Finds That FDA's Final Laboratory Developed Tests Rule Will Hinder Patient Care For Underserved Communities 9/5/2024

    Today, the Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) released the latest results from an ongoing survey that ADLM has been conducting to determine how the Food and Drug Administration's (FDA's) final laboratory developed tests rule will impact patient care.

  5. PHC Launches LiCellMo Live Cell Metabolic Analyzer For Real-Time Visualization Of Cellular Metabolism In Cell And Gene Therapies 9/4/2024

    PHC Corporation Biomedical Division (headquarters: Chiyoda-ku, Tokyo, President: Nobuaki Nakamura; hereafter Biomedical Division) announced today the commercial launch of LiCellMo, a live cell metabolic analyzer that allows researchers to visualize metabolic(*1) changes in cell cultures, providing a more complete picture of cell activity for research uses in cell and gene therapies (CGT).

  6. QIAGEN And Lilly Collaborate To Support Development Of A QIAstat-Dx IVD Panel That Identifies Patients At Risk For Developing Alzheimer's Disease 9/4/2024

    QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it has entered into a collaboration with Eli Lilly and Company to support the development of a QIAstat-Dx in-vitro diagnostic (IVD) to detect APOE genotypes which can play a role in the diagnosis of Alzheimer’s disease.

  7. Sapio Sciences Advances The World's First Ai-Powered Lab Assistant 9/3/2024

    Sapio Sciences, the science-aware lab informatics platform, today announced significant enhancements to Sapio ELaiN, the pioneering AI-powered lab assistant that helps scientists streamline processes and work more efficiently.

  8. Space-Based Experiments To Advance Early Cancer Detection Through Blood Tests 9/3/2024

    The University of Notre Dame is leading a series of groundbreaking experiments onboard the International Space Station (ISS) to revolutionize early cancer detection.

  9. PathAI Collaborates With Goldpath To Elevate Digital Pathology Capabilities With AISight Image Management System 9/3/2024

    PathAI, a global leader in digital pathology, announced today that GoldPath, an independent pathology service provider based in Duarte, California, has adopted the AISight1 Image Management System (IMS).

  10. Rigaku: Novel Electron Density Topography Technology To Reveal Biological Macromolecules' Properties 9/3/2024

    Rigaku Corporation, a Rigaku Holdings Group company and global partner for X-ray analysis from Lab to Fab (headquarters: Akishima, Tokyo; president and CEO: Jun Kawakami; "Rigaku"), has developed a technology called Electron Density Topography (“EDT”), patents pending.